Purdue Sues Impax, Ranbaxy Over Generic OxyContin
Purdue Pharma LP hit Ranbaxy Inc. and Impax Laboratories Inc. with patent infringement suits Friday in New York federal court, challenging their plans for generic versions of Purdue's painkiller OxyContin....To view the full article, register now.
Already a subscriber? Click here to view full article